Gene-Based Multiclass Cancer Diagnosis with Class-Selective Rejections

Table 7

Asymmetric cost matrix of the loss function.

		Patient class
		Normal	SCLC	LCLC	SCC	AC2	AC3	AC1
	Normal	0	1	1	1	1	1	1
	SCLC	1	0	1	1	1	1	1
	LCLC	1	1	0	0.9	0.9	1	1
	SCC	1	1	0.9	0	0.9	1	0.9
	AC2	1	1	0.9	0.9	0	0.9	0.9
Predicted decision	AC3	1	1	0.9	0.9	0.9	0	0.9
	AC1	1	1	0.9	0.9	0.9	0.9	0
	{LCLC, SCC, AC3 }	1	1	0.6	0.6	0.9	0.2	0.9
	All tumors	1	0.2	0.6	0.6	0.2	0.2	0.5
	All classes	0.6	0.2	0.6	0.6	0.2	0.6	0.6